Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/9309800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 29.03.2026. Verfasst von Ney de Carvalho Almeida und 19 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology and Molecular Biology Laboratory, State University of Ceará, Campus do Itaperi, Fortaleza, 60714-903, Ceará, Brazil, uece.br. Hauptthemen laut MEDLINE: Infectious bronchitis virus, SARS-CoV-2, COVID-19, COVID-19 Vaccines. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Occupational exposure to infectious bronchitis virus (IBV) has been associated with cross‐reactivity to other coronaviruses such as SARS‐CoV‐2. In this study, we investigated the immune response of IBV using reconstituted samples of the commercial H120 Mass‐I vaccine (Zoetis) against SARS‐CoV‐2 infection. Bioinformatics analyses, serological assays, and neutralization tests were conducted to evaluate the neutralizing capacity of anti‐IBV antibodies against SARS‐CoV‐2 in serum samples from poultry farm workers exposed to the IBV‐H120 vaccine. Mouse immunization assays and flow cytometry analysis were conducted to characterize the immune response triggered by IBV‐H120. Finally, a histological analysis of the lungs of Syrian hamsters vaccinated with IBV and challenged with SARS‐CoV‐2 (Wuhan and Delta strains) was conducted to evaluate the protective potential of the vaccine. Neutralizing antibodies against IBV‐H120 were detected in the serum of poultry farm workers, indicating cross‐reactivity with SARS‐CoV‐2. The immune response in mice immunized with IBV‐H120 demonstrated that only the intranasal and oral routes were effective against SARS‐CoV‐2. An increase in the percentage of CD19 + induced by IBV‐H120 vaccination was demonstrated by flow cytometry. Intranasal administration of the IBV‐H120 vaccine reduced lung damage in Syrian hamsters against the Wuhan and Delta variants of SARS‐CoV‐2. IBV‐H120 elicited both humoral and cellular immune responses in mice and reduced lung damage in hamsters challenged with the Wuhan and Delta variants. This indicates that it could be an improved vaccine for controlling SARS‐CoV‐2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology and Molecular Biology Laboratory, State University of Ceará, Campus do Itaperi, Fortaleza, 60714-903, Ceará, Brazil, uece.br.
- Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil, ufc.br.
- Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil, ufc.br.
- Oswaldo Cruz Foundation in Ceará, Eusebio, Brazil.
- Federal Institute of Education, Science and Technology of Ceará, Campus Horizonte, Horizonte, Ceará, Brazil.
- Department of Physics, Federal University of Ceará, Fortaleza, Ceará, Brazil, ufc.br.
ORCID-Profile: Natália do Vale Canabrava, Maria Izabel Florindo Guedes
Förderung
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Carvalho Almeida, N., van Tilburg, M. F., da Silva, B. B., da Silva Neto, J. X., Moura, L. F. W. G., do Vale Canabrava, N., Cavalcante, D. I. M., Wong, D. V. T., Lima, R. C. P., Pinheiro, D. P., Costa, D. A., Farias, D. A. B., de Morais, P. A., Freire, V. N., de Paula, V. F., Maia, F. F., Wilke, D. V., Furtado, G. P., Florean, E. O. P. T., & Guedes, M. I. F. (2026). Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/9309800
Vancouver
de Carvalho Almeida N, van Tilburg MF, da Silva BB, da Silva Neto JX, Moura LFWG, do Vale Canabrava N, et al. Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/9309800
BibTeX
@article{deCarvalhoAlmeida2026,
author = {de Carvalho Almeida, Ney and van Tilburg, Mauricio Fraga and da Silva, Bruno Bezerra and da Silva Neto, João Xavier and Moura, Luiz Francisco Wemmenson Gonçalves and do Vale Canabrava, Natália and Cavalcante, Diane Isabelle Magno and Wong, Deysi Viviana Tenazoa and Lima, Roberto César Pereira and Pinheiro, Daniel Pascoalino and Costa, Dayane Alves and Farias, Danúbio Andrade Bezerra and de Morais, Pablo Abreu and Freire, Valder Nogueira and de Paula, Valdir Ferreira and Maia, Francisco Franciné and Wilke, Diego Veras and Furtado, Gilvan Pessoa and Florean, Eridan Orlando Pereira Tramontina and Guedes, Maria Izabel Florindo},
title = {Attenuated Infectious Bronchitis Virus (IBV) Vaccination Induces Protective Humoral and Cellular Immunity Against SARS‐CoV‐2 in Mammals},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/9309800}
}
EUVIMED